Results 281 to 290 of about 7,216,417 (314)

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

Molecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg, Joachim von Braun, Julio Celis, Anton Berns, Michael Baumann, Tit Albreht, Nancy Abou‐Zeid, Vanderlei Bagnato, Christian Brandts, Chien‐Jen Chen, Massimiliano di Pietro, Manjit Dosanjh, Thomas Dubois, Alexander Eggermont, Angelika Eggert, Ingemar Ernberg, Sara Faithfull, Johannes Förner, Stefan Fröhling, Manuel Heitor, Leroy Hood, Wei Jiang, Bengt Jönsson, Ravi Kannan, Maria Leptin, Su Li, Peter Lindgren, Douglas Lowy, Jun Ma, Alex Markham, Péter Nagy, Simon Oberst, M. Iqbal Parker, Danielle Rodin, Kevin Ryan, Joachim Schüz, Richard Sullivan, Josep Tabernero, Peter Turkson, Oliver Várhelyi, Harold Varmus, Chijie Wang, Elisabete Weiderpass, Nils Wilking   +43 more
wiley   +1 more source

Circulating Fibroblast Growth Factor 21 (FGF21) as a Prognostic and Diagnostic Biomarker in Hepatocellular Carcinoma. [PDF]

J Hepatocell Carcinoma
Eid JR, Yalciner M, Xiao L, Sun R, Kannan MK, Hassan M, Rashid A, Chamseddine S, Tran Cao HS, Amin HM, Kaseb AO.   +10 more
europepmc   +1 more source

Cell surface interactome analysis identifies TSPAN4 as a negative regulator of PD‐L1 in melanoma

Molecular Oncology, EarlyView.
Using cell surface proximity biotinylation, we identified tetraspanin TSPAN4 within the PD‐L1 interactome of melanoma cells. TSPAN4 negatively regulates PD‐L1 expression and lateral mobility by limiting its interaction with CMTM6 and promoting PD‐L1 degradation.
Guus A. Franken, Andrea Abel Gutierrez, Imke van Rossum, Cornelia G. Spruijt, Michiel Vermeulen, Guido van Mierlo, Blanca Scheijen, Annemiek B. van Spriel   +7 more
wiley   +1 more source

Utility of Placental Growth Factor for the Prediction of Miscarriage in the First Trimester of Pregnancy: A Case-Control Study. [PDF]

Int J Womens Health
Kuspanova M, Gaiday A, Bermagambetova S, Dinets A, Amirbekova Z, Zhylkaidar G, Sarkuchikova G, Sakhanova S, Amantay A, Aidarkhanova M, Tussupkaliyev A.   +10 more
europepmc   +1 more source

Fibroblast growth factor 9 activates fibroblast activation and drives the progress of shoulder stiffness. [PDF]

Front Cell Dev Biol
Xu J, Yu W, Kang Y, Yang D, Liu Y, Bi W, Yu H, Qi B, Guo B.   +8 more
europepmc   +1 more source

The Transforming Growth Factor β Genes and Susceptibility to Musculoskeletal Injuries in a Physically Active Caucasian Cohort. [PDF]

J Clin Med
Rzeszutko-Bełzowska A, Leońska-Duniec A.   +1 more
europepmc   +1 more source

Body mass index mediates the association between serum fibroblast growth factor-19 and diabetes. [PDF]

J Diabetes Metab Disord
Liu L, Liu S, Zhen J, Ren L, Zhao G, Liang J, Xu A, Li C, Wu J, Cheung BM.   +9 more
europepmc   +1 more source

Transforming Growth Factor-β Signaling in Alcohol-Associated Liver Disease: A Multicellular Perspective. [PDF]

Am J Pathol
Zou H, Wang S, Huang C, Dooley S, Meindl-Beinker NM.   +4 more
europepmc   +1 more source

Pachydermoperiostosis Presenting With Gynecomastia and Low Insulin-Like Growth Factor-1 Levels: A Diagnostic Challenge. [PDF]

Cureus
Amith Priyansu J, U K R, Amalakanti S, Asif M, Chitturi SV.   +4 more
europepmc   +1 more source